作者: Y. Lalami , A. Awada
DOI: 10.1016/J.CTRV.2016.01.001
关键词:
摘要: It is now well established that head and neck cancer carcinogenesis characterized by genetic instability several immune defects, leading to unique host-tumor interactions. In such condition, recent improved comprehension relevant findings could lead identification of innovative molecular therapeutic targets, achieving considerable clinical translational research. This review aims summarize highlight most scientific rationale in this era immunotherapy revival, correlate it the near future practice for management challenging disease.